Technitrol divests Medtech components supply business
This article was originally published in The Gray Sheet
Executive Summary
Electronic component maker Technitrol sells its medical technology components supply business to private equity investor Altor Fund III for $200 million in cash June 2. Based in Denmark, the divested Medtech business generated $110 million in sales over the last year, and includes "armature receivers, high-end microphones, and electromechanical devices for the hearing aid, high-end audio headset, and medical device markets.